ARCHIVES

Trading In Stock Of U.S. Bioscience Halted, Newsletter Report Cited

This article is from The Cancer Letter archive.

Vol. 18 No. 39 | October 9, 1992

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Approved In August 2002 By NCI

September 27, 2002

Cancer Advocates Use Benefit Analysis To Press For Funds

May 11, 1990

Utah, NIEHS Report Finding BRACA1 Gene For Familial Breast, Ovarian Cancer

September 23, 1994

NCI’s Chabner Cautions Against 3-Hour Taxol Infusion, May Lower Response Rate

October 22, 1993

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

January 28, 2011

Reimbursement Policy By Philadelphia Blue Cross Further Explained

April 21, 1989